These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A controlled trial of colon bypass in chronic hepatic encephalopathy. Resnick RH; Ishihara A; Chalmers TC; Schimmel EM Gastroenterology; 1968 Jun; 54(6):1057-69. PubMed ID: 5656325 [No Abstract] [Full Text] [Related]
3. [Dupuytren's contracture and internal diseases]. Rhomberg HP Wien Klin Wochenschr; 1967 Oct; 79(43):793-5. PubMed ID: 5589331 [No Abstract] [Full Text] [Related]
4. ["Flapping tremor" in hepatic encephalopathy. Physiopathological study]. Molina-Negro P; Emond M; Hardy J Union Med Can; 1972 Feb; 101(2):242-6. PubMed ID: 4666312 [No Abstract] [Full Text] [Related]
5. [Effect of a protein-free extract of calf-blood (actihaemyl) on liver, muscle and brain metabolism in liver-cirrhosis patients with and without portal encephalopathy]. Müting D; Schieffer H; Reikowski J; Ecknauer R Med Welt; 1973 Dec; 24(52):2075-8. PubMed ID: 4779605 [No Abstract] [Full Text] [Related]
6. [Early myocardial infarction in alcoholics]. Kruś S; Kluge P; Pykało R Pol Tyg Lek; 1983 Jul; 38(27):839-41. PubMed ID: 6657523 [No Abstract] [Full Text] [Related]
7. [Statistical criteria for quantitative evaluation of the prognosis of liver cirrhosis]. Franzini P; Marubini E; Cereda UG; Lucchelli PE; Navassa G Minerva Med; 1968 Dec; 59(104):5839-53. PubMed ID: 5718243 [No Abstract] [Full Text] [Related]
8. Primary liver cancer in cirrhosis of the alcoholic. Leevy CM; Gellene R; Ning M Ann N Y Acad Sci; 1964 Apr; 114(2):1026-40. PubMed ID: 5220104 [No Abstract] [Full Text] [Related]
9. Increased incidence of cholelithiasis in Laënnec's cirrhosis. A postmortem evaluation of pathogenesis. Nicholas P; Rinaudo PA; Conn HO Gastroenterology; 1972 Jul; 63(1):112-21. PubMed ID: 5055737 [No Abstract] [Full Text] [Related]
10. Effect of selection in controlled clinical trials. A supplement to the CSL prednisone trial in cirrhosis. Juhl E; Hilden M; Tygstrup N Scand J Gastroenterol Suppl; 1971; 9():171-5. PubMed ID: 5284140 [No Abstract] [Full Text] [Related]
11. [Value of lactulose in the treatment of chronic porto-cave encephalopathy (20 cases)]. Geffroy Y; Segrestin M; Geffroy PY Therapeutique; 1970 Nov; 46(9):897-901. PubMed ID: 5486138 [No Abstract] [Full Text] [Related]
12. [Encephalopathy after portacaval shunt: diagnostic and predictive values of the electroencephalographic response after diazepam administration]. Favre B; Grange D; Franco D; Ferrey G; Mahuzier G; Bismuth H Gastroenterol Clin Biol; 1982; 6(6-7):526-30. PubMed ID: 7117762 [No Abstract] [Full Text] [Related]
13. The pathology of hepatic cirrhosis. A study of 70 biopsies and their clinical correlations. Correia JP; Baptista AS; Alves MP Acta Hepatosplenol; 1971; 18(6):470-81. PubMed ID: 5134147 [No Abstract] [Full Text] [Related]
15. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy. Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591 [No Abstract] [Full Text] [Related]
16. Cerebral dysfunction in alcoholics. A psychometric investigation. Claeson LE; Carlsson C Q J Stud Alcohol; 1970 Jun; 31(2):317-23. PubMed ID: 5482227 [No Abstract] [Full Text] [Related]
17. [Remarks on liver cirrhosis with epidemiologic interest]. Spigliati P; Cercone S; Sgrò G; Fusco L Minerva Med; 1982 May; 73(21):1455-62. PubMed ID: 7088368 [No Abstract] [Full Text] [Related]
19. [Ascites and alcoholic cirrhosis]. Gastard J; Cousin P; Boullier G Ann Gastroenterol Hepatol (Paris); 1971; 7(2):137-43. PubMed ID: 5573348 [No Abstract] [Full Text] [Related]
20. [Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy]. Girard PF; Trillet M; Kopp N Rev Neurol (Paris); 1972 Nov; 127(5):560-3. PubMed ID: 4668744 [No Abstract] [Full Text] [Related] [Next] [New Search]